![]() CKS-17 structure
|
Common Name | CKS-17 | ||
---|---|---|---|---|
CAS Number | 99273-04-8 | Molecular Weight | 1942.27000 | |
Density | 1.41±0.1 g/cm3 (20 °C, 760 mmHg) | Boiling Point | N/A | |
Molecular Formula | C87H148N26O24 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CKS-17CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions[1][2][3]. |
Name | L-Leucine, L-leucyl-L-glutaminyl-L-asparaginyl-L-arginyl-L-arginylglycyl-L-leucyl-L-α-aspartyl-L-leucyl-L-leucyl-L-phenylalanyl-L-leucyl-L-lysyl-L-α-glutamylglycylglycyl |
---|---|
Synonym | More Synonyms |
Description | CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | CKS-17 (THP-1 cells) induces increased intracellular cAMP via activation of adenylate cyclase[1]. CKS-17 (15 μM; EL4 cells) inhibits interleukin-2 production by tumor cell products[3]. |
In Vivo | CKS-17 (10 μM; i.d.; B6AF1 mice and C57BL/6J mice) inhibits delayed-type hypersensitivity (DTH) reactions to sheep erythrocytes in the feet of mice[2]. Animal Model: B6AF1 mice and C57BL/6J mice with DTH models[2] Dosage: 10 μM Administration: Intradermal injection, into the right hind footpad Result: Had a transient depressive effect on DTH reaction. |
Density | 1.41±0.1 g/cm3 (20 °C, 760 mmHg) |
---|---|
Molecular Formula | C87H148N26O24 |
Molecular Weight | 1942.27000 |
Exact Mass | 1941.12000 |
PSA | 839.52000 |
LogP | 5.14200 |
1067: PN: US20090175821 SEQID: 1339 claimed protein |
CKS-17 |